Last edition
News about "Health Canada "
Novartis Wins Health Canada Approval for RHAPSIDO in CSU
Novartis has received Health Canada approval for RHAPSIDO (remibrutinib), a new oral treatment for adults with Chronic Spontaneous Urticari (CSU).
Health Canada | 29/07/2026 | By News Bureau
Biocon Receives Health Canada Approval for Yesintek Autoinjector Pen
Biocon has received Health Canada approval for the Yesintek autoinjector pen to treat plaque psoriasis, psoriatic arthritis, Crohn's Disease (CD) and Ulcerative Colitis (UC).
Health Canada | 29/07/2026 | By News Bureau
WuXi Biologics Secures 4th EMA GMP Certification for Suzhou Facility
WuXi Biologics’ Suzhou Biosafety Testing Center has received its 4th EMA GMP certification, supporting European Union (EU) Marketing Authorisation (MA) applications for 19 biologics from 13 stakeholders.
Health Canada | 18/06/2026 | By News Bureau
Health Canada Authorises Livmarli Tablet for Cholestatic Pruritus in Alagille Syndrome
Mirum Pharmaceuticals receives Health Canada approval for Livmarli tablet formulation, expanding dosing options for eligible Alagille syndrome patients with cholestatic pruritus.
Health Canada | 07/02/2026 | By News Bureau | 174
Health Canada Grants Authorisation for Leqembi (Lecanemab)
BioArctic has the right to commercialise Leqembi in the Nordic region together with Eisai and the two companies are preparing for a joint commercialisation in the region.
Health Canada | 28/10/2025 | By Dineshwori | 255
Acclaro Medical has also partnered with Xcite Technology to spearhead commercialisation efforts across Canada.
Health Canada | 27/06/2025 | By Abha | 525
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy